Investors

Media Coverage

To receive regular updates, including all of CLINUVEL's announcements, you can subscribe to our email database here.

 A selection of press coverage is listed below

Title Link
Aus dem Schatten hervortreten NZZ
Exposure to sunlight burns my skin – now I can come out the shadows thanks to new drug Bournemouth Echo
INTERVIEW: CLINUVEL's Philippe Wolgen on Scenesse and the patient factor Scrip
CLINUVEL's subisidiary develops drug candidate for vitiligo Biospectrum Asia
Wanneer de zon een hel wordt VTM News
Out of the shadows (content only available in the USA) NBC Dateline
11-Year-Old 'Allergic' to Sunlight Good Morning America
Implanted drug improves tolerance of sunlight in rare condition Reuters
Drug Offers Hope Against Disease Where Sunlight Causes Pain Health Day
New Treatment Inspires Hope for the Battle Against Sun Allergy Good Morning America
Philippe Wolgen of Clinuvel Pharmaceuticals driven by competition  The Australian

Quick Links